Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory
Pharma
J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win
J&J says it plans to present the Tecvayli combo data to health authorities and disclose the detailed myeloma results at an upcoming medical meeting.
Fraiser Kansteiner
Oct 16, 2025 8:10am
Regulatory tracker: GSK's Shingrix gains China expansion
Oct 15, 2025 1:30pm
Regulatory, policy uncertainties harm biopharma planning: Cytiva
Oct 8, 2025 3:11pm
FDA drafts new policies to boost US drug production
Oct 3, 2025 3:52pm
How a government shutdown will affect the FDA
Oct 1, 2025 11:29am
FDA official chastises Aurinia med in now-deleted LinkedIn post
Sep 30, 2025 10:15am
